@longevitytech.bsky.socialLicensing deal brings Amprion’s misfolded-protein test closer to European trial sites, aiming to speed up neurodegenerative drug development.
Link as first comment.
#longevity #geroscience #amprion #neurodegenerative #drugdevelopment
@fiosgenomics.bsky.socialBiomarker Validation: Avoiding Misleading Results
Biomarker validation is crucial, misuse can lead to false results and poor outcomes.
⬇️Learn more in our blog:⬇️
https://www.fiosgenomics.com/biomarker-validation-avoiding-misleading-results
@gmj-georgia.bsky.socialThe US FDA is piloting a new expedited pathway to speed up early-stage clinical trial approvals, citing competition from China as a p… #Clinicaltrials #Drugdevelopment #FDA #Pharmaceuticalinnovation #Regulatorypolicy #Clinicaltrials #Drugdevelopment #FDA #Pharmaceuticalinnovation #Regulatorypol…
@cpathinstitute.bsky.socialDive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/5gr25ca12s
@fiosgenomics.bsky.socialWant to know all the ways that #biotechnology companies can benefit from bioinformatics? This short blog has the answers!
https://www.fiosgenomics.com/bioinformatics-applications-in-biotechnology
@genelife.bsky.socialPhase I: fewest patients, shortest duration, most consequential data in drug development.
Dose selection, PK profiling, safety characterization — every Phase III decision traces back here.
@cpathinstitute.bsky.socialDive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/x470km8db6
@cpathinstitute.bsky.socialDive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/h4eqx8lfxn
@longevitytech.bsky.socialTHPharm is using AI to find new uses for a drug already in Phase 3 trials, turning proven biology into a search for new therapeutic opportunities.
Link as first comment.
@fiosgenomics.bsky.socialEver wondered what a #bioinformatics report actually looks like? Discover our reports, the information they contain & what our clients think of them at https://www.fiosgenomics.com/bioinformatics-report-your-data-explained #dataanalysis #biology #drugdevelopment
@healthcaretoday.bsky.socialThe Medicines and Healthcare products Regulatory Agency has published a position paper clarifying how microbiome-based medicines can be made available for patients in the UK.
healthcaretoday.com/article/mhra...
#MHRA #Microbiome #DrugDevelopment #LifeSciences #Regulation
@genelife.bsky.socialIndia's 2026 NDCT amendments: what actually changed vs what the headlines suggested.
Changed: pre-clinical manufacturing approval → prior intimation. BA/BE initiation. Review timeline 90 → 45 days.
#ClinicalTrials #India #CDSCO #NDCT2026 #RegulatoryStrategy #DrugDevelopment #Pharma #CRO